Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

Clinical trial NCT06500819 · RECRUITING

Trial details

NCT number: NCT06500819
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroblastoma Sarcoma Osteosarcoma

Start date: 2024-07-11
Primary completion: 2029-07-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.